Hybrid nanoparticles consisting of
lipids and the biodegradable
polymer,
poly (D,L-lactide-co-glycolide) (PLGA), were developed for the targeted delivery of the anticancer
drug,
docetaxel. Transmission electron microscopic observations confirmed the presence of a
lipid coating over the polymeric core. Using coumarin-6 as a
fluorescent probe, the uptake efficacy of RGD conjugated
lipid coated nanoparticles (RGD-L-P) by C6 cells was increased significantly, compared with that of
lipid-
polymer hybrid nanoparticles (L-P; 2.5-fold higher) or PLGA-nanoparticles (PLGA-P; 1.76-fold higher). The superior
tumor spheroid penetration of RGD-L-P indicated that RGD-L-P could target effectively and specifically to C6 cells overexpressing
integrin α(v)β3. The anti-proliferative activity of
docetaxel-loaded RGD-L-P against C6 cells was increased 2.69- and 4.13-fold compared with L-P and PLGA-P, respectively. Regarding biodistribution, the strongest brain-localized fluorescence signals were detected in
glioblastoma multiforme (GBM)-bearing rats treated with 1,10-Dioctadecyl-3,3,30,30-tetramethylindotricarb-ocyanine
iodide (DiR)-loaded RGD-L-P, compared to rats treated with DiR-loaded L-P or PLGA-P. The median survival time of GBM-bearing rats treated with
docetaxel-loaded RGD-L-P was 57 days, a fold increase of 1.43, 1.78, 3.35, and 3.56 compared with animals given L-P (P < 0.05), PLGA-P (P < 0.05),
Taxotere (P < 0.01) and saline (P < 0.01), respectively. Collectively, these results support RGD-L-P as a promising drug delivery system for the specific targeting and the treatment of GBM.